American International Group’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
– Sell
-19,959
Closed -$2.7M – 282
2024
Q1
$2.7M Sell
19,959
-273
-1% -$36.1K 0.01% 917
2023
Q4
$2.73M Buy
20,232
+387
+2% +$50.3K 0.01% 903
2023
Q3
$2.69M Buy
19,845
+3,897
+24% +$532K 0.02% 874
2023
Q2
$2.28M Sell
15,948
-282
-2% -$41.5K 0.01% 935
2023
Q1
$2.25M Sell
16,230
-186
-1% -$25K 0.01% 930
2022
Q4
$2.23M Sell
16,416
-1,750
-10% -$219K 0.02% 920
2022
Q3
$1.99M Buy
18,166
+512
+3% +$65K 0.01% 934
2022
Q2
$2.33M Buy
17,654
+298
+2% +$39.1K 0.02% 910
2022
Q1
$2.3M Buy
+17,356
New +$2.08M 0.01% 975
2016
Q2
– Sell
-17,102
Closed -$963K – 3149
2016
Q1
$963K Buy
17,102
+571
+3% +$34.3K ﹤0.01% 1521
2015
Q4
$1.12M Sell
16,531
-1,420
-8% -$93.1K ﹤0.01% 1422
2015
Q3
$1.14M Sell
17,951
-15,664
-47% -$1.03M 0.01% 1363
2015
Q2
$2.14M Buy
33,615
+5,052
+18% +$346K 0.01% 1116
2015
Q1
$1.95M Sell
28,563
-663
-2% -$46.1K 0.01% 1179
2014
Q4
$2.06M Sell
29,226
-1,863
-6% -$133K 0.01% 1110
2014
Q3
$2.22M Sell
31,089
-1,667
-5% -$122K 0.01% 1071
2014
Q2
$2.43M Sell
32,756
-11,292
-26% -$816K 0.01% 1033
2014
Q1
$2.86M Buy
44,048
+19,528
+80% +$1.26M 0.01% 946
2013
Q4
$1.46M Sell
24,520
-789
-3% -$42.9K 0.01% 1229
2013
Q3
$1.31M Buy
25,309
+4,758
+23% +$239K 0.01% 1236
2013
Q2
$972K Buy
+20,551
New +$1.05M 0.01% 1402

Other funds holding AZN

American International Group's AZN Position: Q2 2024 in Review

American International Group sold out of AstraZeneca (AZN) in Q2 2024, closing a stake of 19,959 shares — an estimated $2.7M sold.

American International Group first reported a position in AZN in Q2 2013 and held it in 21 quarters. The position peaked at $2.86M in Q1 2014. 1,212 funds tracked by Wall St. Rank hold AZN as of Q2 2024.

  • American International Group reported no remaining AstraZeneca position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 19,959 AstraZeneca shares in Q2 2024, an estimated $2.7M.
  • American International Group first reported a position in AstraZeneca in Q2 2013 and held it in 21 quarters.
  • American International Group's AstraZeneca position peaked at $2.86M in Q1 2014.
  • 1,212 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.